Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3228913 | Annals of Emergency Medicine | 2014 | 13 Pages |
Abstract
Current evidence does not support routine ECG and electrolyte screening before single oral ondansetron dose administration to individuals without known risk factors. Screening should be targeted to high-risk patients and those receiving ondansetron intravenously.
Related Topics
Health Sciences
Medicine and Dentistry
Emergency Medicine
Authors
Stephen B. MDCM, MSc, Elizabeth BA, MLS, Maggie MD, Yaron MD,